Clinical Trials Sponsored by Ablon Skin Institute Research Center

Total 6244 results

H. Lee Moffitt Cancer Center and Research Institute

Completed

Dose Escalation Study of Preoperative SBRT for High Risk Prostate Cancer

Prostate Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

Health Beliefs, Behaviors, and Healthcare Experiences Among United States Young and Mid-Age Adults

HPV Vaccine Knowledge

United States
H. Lee Moffitt Cancer Center and Research Institute

Terminated

Study of T-VEC in Locally Advanced Cutaneous Angiosarcoma

Angiosarcoma of Skin

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

Capecitabine and Lenvatinib With External Radiation in Rectal Adenocarcinoma

Rectal Cancer | Rectal Adenocarcinoma

United States
H. Lee Moffitt Cancer Center and Research Institute

Terminated

FOLFIRINOX in Metastatic High Grade Gastroenteropancreatic Neuroendocrine Carcinomas

Pancreatic Cancer | Gastro-enteropancreatic Neuroendocrine Tumor | Neuroendocrine Carcinomas of Pancreas | Islet Cell Carcinoma

United States
Children's National Research Institute
M.D. Anderson Cancer Center

Completed

Cytotoxic T Cells to Prevent Virus Infections

CMV | EBV | Adenovirus Infections

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

Randomized Controlled Trial of Endoscopic Dilation: Triamcinolone Injection

Dysphagia

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

In Vivo Treg Expansion and Graft-Versus-Host Disease Prophylaxis

Graft-Versus-Host-Disease

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

Feasibility Study of Ultrasound Elastography Detecting Prostate Cancer

Prostate Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

Busulfan Safety/Efficacy as Conditioning Prior to Hematopoietic Cell Transplantation (HCT)

Lymphoma | Myelodysplastic Syndromes | Myeloproliferative Disorders | Myeloma | Leukemia, Lymphocytic

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

Exploration of Immune Response to Early PCV13 Vaccination in Conjunction With Autologous Transplant (PCV13)

Multiple Myeloma

United States
H. Lee Moffitt Cancer Center and Research Institute

Terminated

Selinexor in Combination With Irinotecan in Adenocarcinoma of Stomach and Distal Esophagus

Gastric Cancer | Esophageal Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Terminated

Bicarbonate for Tumor Related Pain

Neoplasm Related Pain (Acute) (Chronic)

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

Pilot Study to Validate Metallic Markers for Image Guided Radiation Therapy for Breast Cancer Tx

Breast Cancer

United States
Tae Gun Shin
National Research Foundation of Korea

Completed

Ascorbic Acid and Thiamine Effect in Septic Shock (ATESS)

Sepsis | Septic Shock

Korea, Republic of
Oklahoma Medical Research Foundation
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Completed

Genetic Study of Lupus Patients and Their Families

Systemic Lupus Erythematosus

United States
H. Lee Moffitt Cancer Center and Research Institute

Recruiting

Targeting ODC as an Immunotherapeutic Target in STK11 (LKB1) Pathway-Deficient NSCLC (DFMO)

Lung Cancer | Non Small Cell Lung Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Recruiting

Non-Invasive Biomarkers in Prostate Cancer Disease Management

Prostate Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Recruiting

The MONITOR Study: Remote Monitoring Of a Nutrition Intervention To Optimize Treatment Response

Pancreatic Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Recruiting

The ENHANCE Study: Exercise and Nutrition in Head And Neck CancEr Survivors

Oropharynx Cancer | Oral Cavity Cancer | Larynx Cancer | Hypopharynx Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Recruiting

The Pancreas Interception Center (PIC) for Early Detection, Prevention, and Novel Therapeutics

Lynch Syndrome | Pancreatic Ductal Adenocarcinoma | Chronic Pancreatitis | Pancreatic Cyst | Ataxia Telangiectasia | FAP | Peutz-Jeghers Syndrome | PALB2 Gene Mutation | BRCA Mutation | Fatty Pancreas | Genetic Pancreatic Cancer | Genetic Pancreatitis | Familial Atypical Multiple Mole-Melanoma

United States
H. Lee Moffitt Cancer Center and Research Institute

Not yet recruiting

Wet Heparinized Suction for Abdominal Cancer (EUS Heparin)

Cancer | Cancer of Liver | Cancer of Pancreas | Cancer of Stomach | Cancer of Esophagus

United States
H. Lee Moffitt Cancer Center and Research Institute

Active, not recruiting

Reduced Intensity Flu/Mel/TBI Conditioning for HAPLO HCT Patients With Hematologic Malignancies

Acute Myeloid Leukemia | Myelodysplastic Syndromes | Hodgkin Lymphoma | Burkitt Lymphoma | Acute Lymphoblastic Leukemia | Mantle Cell Lymphoma | Lymphoplasmacytic Lymphoma | Chronic Myelogenous Leukemia | Prolymphocytic Leukemia | Myeloproliferative Neoplasm | Relapsed Follicular Lymphoma | Relapsed T-Cell Lymphoma and other conditions

United States
H. Lee Moffitt Cancer Center and Research Institute

Active, not recruiting

STRONG Program for Cancer Patients

Gastrointestinal Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Active, not recruiting

CD8 Depleted, Non-engrafting, HLA Mismatched Unrelated Infusion With MDS and Secondary AML

Myelodysplastic Syndromes | Secondary Acute Myeloid Leukemia

United States
H. Lee Moffitt Cancer Center and Research Institute

Active, not recruiting

Transarterial Chemoperfusion: Cisplatin, Methotrexate, Gemcitabine for Unresectable Pleural Mesothelioma

Mesothelioma | Malignant Pleural Mesothelioma

United States
H. Lee Moffitt Cancer Center and Research Institute

Active, not recruiting

Use of a Proliferation Saturation Index to Determine Personalized Radiotherapy for HPV + Oropharyngeal Cancers

Oropharyngeal Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Active, not recruiting

Vemurafenib With Lymphodepletion Plus Adoptive Cell Transfer & High Dose IL-2 Metastatic Melanoma

Metastatic Melanoma

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

Project HEALS (Helping and Empowering pAtients for Living a Life Smoke-free

Smoking | Tobacco Use | Lung Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Terminated

Intratumorally-Administered Topotecan Using Convection-Enhanced Delivery in Patients With Grade III/ IV Glioma

Glioma of Brain

United States
H. Lee Moffitt Cancer Center and Research Institute

Active, not recruiting

Adaptation Of An HPV Education Resource To Promote HPV Vaccination

HPV Vaccine | HPV

United States, Puerto Rico
H. Lee Moffitt Cancer Center and Research Institute

Completed

Developing and Testing a Spanish-Language Intervention to Reduce Cancer-Related Sleep Disturbance

Sleep Disturbance

United States, Puerto Rico
H. Lee Moffitt Cancer Center and Research Institute

Completed

Stereotactic Body Radiotherapy and Concurrent Cisplatin for Re-Irradiation of Unresectable, Recurrent Squamous Cell Carcinomas of Head and Neck

Squamous Cell Carcinoma of the Head and Neck

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

Feasibility Study for Electroacupuncture for Chemotherapy- Induced Peripheral Neuropathy (CIPN)

Chemotherapy-induced Peripheral Neuropathy

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

Protocol for High-Risk Assessment, Screening, and Early Detection of Pancreatic Cancer

Pancreatic Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

Capecitabine or 5-FU With Pegylated Interferon Alpha-2b in Unresectable/Metastatic Cutaneous Squamous Cell Carcinoma

Carcinoma, Squamous Cell | Squamous Cell Carcinoma of Skin

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

Ofatumumab as Primary Therapy of Chronic Graft Versus Host Disease

Chronic Graft Versus Host Disease

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

Calcineurin Inhibitor-Free GVHD Prevention Regimen After Related Haplo PBSCT

Myelodysplastic Syndromes | Primary Myelofibrosis | Multiple Myeloma | Hodgkin Lymphoma | Non-Hodgkin's Lymphoma | Chronic Myelomonocytic Leukemia | Chronic Myeloid Leukemia | Acute Leukemia in Remission

United States
H. Lee Moffitt Cancer Center and Research Institute

Withdrawn

A Phase I/II Trial of HER-2/Neu Pulsed DC1 Vaccine Combined With Trastuzumab for Patients With DCIS

Breast Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

Enzalutamide in Combination With Gemcitabine and Cisplatin in Bladder Cancer

Carcinoma, Transitional Cell | Bladder Cancer | Urethra Cancer | Ureter Cancer | Renal Pelvis Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Terminated

Fermented Wheat Germ Extract in Women With Ovarian Cancer

Ovarian Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Withdrawn

Biomarker Correlates of Hypoxia in Metastatic Melanoma

Melanoma | Skin Cancer
H. Lee Moffitt Cancer Center and Research Institute

Completed

Graft-Versus-Host Disease (GVHD) Prophylaxis After Allogeneic Peripheral Blood Hematopoietic Cell Transplantation

Acute Graft Versus Host Disease

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

The Human Papillomavirus (HPV) Transmission Pilot Study

Human Papillomavirus Infection

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

Phase II Trial of Pentostatin and Targeted Busulfan (Pento & tBU)

Hematologic Malignancies

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

Chemotherapy Followed By Vaccine Therapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer

Lung Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

Evaluation of Patient Functionality and Utility of Web-Based Personal Health History and Risk Assess

Cancer | Cancer Screening Patients | Patient Volunteers

United States
H. Lee Moffitt Cancer Center and Research Institute

Terminated

Autologous SCT Followed by Dendritic Cell p53 Vaccination in Patients With Limited Stage Small Cell Lung Cancer

Small Cell Lung Cancer

United States
Dattoli Cancer Center and Brachytherapy Research...
Sanofi

Completed

Palladium-103 Seed Implant and Single Daily Dosing of Uroxatral Vs. Twice Daily Dosing of Flomax- A 3 Month Retrospective Efficacy Analysis

Prostate Cancer Patients Undergoing External Radiation and Seed Implantation

United States
AC Camargo Cancer Center
H. Lee Moffitt Cancer Center and Research Institute

Completed

Study of Tamoxifen in Well Differentiated Neuroendocrine Tumors and Hormone Receptor Positive Expression (HORMONET)

Neuroendocrine Tumors | Estrogen Receptor Positive Tumor | Progesterone Receptor Positive Tumor

United States, Brazil

Clinical Trials Sponsored by Ablon Skin Institute Research Center

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cote d'Ivoire

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations